10-K Decoder · All companies

CG Oncology, Inc.

CGON · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$4.04M$1.14M+254%
Operating income−$191M−$115M−66.4%
Net income−$161M−$88.0M−82.9%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 6, 2026

$Q3 2026Year earlierChange
Revenue$1.60M$1.70M−5.9%
Operating income−$63.2M−$51.1M−23.7%
Net income−$56.9M−$43.8M−29.9%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was CG Oncology's revenue in FY2025?
$4.04M in FY2025 (Fiscal year ended Dec 31, 2025), +254% vs $1.14M a year earlier, per its 10-K filed Feb 2026.
Was CG Oncology profitable in FY2025?
No: net income was −$161M and operating income −$191M in FY2025.
What was CG Oncology's revenue in Q3 2026?
$1.60M (−5.9% vs a year earlier), per its Form 10-Q filed Nov 6, 2026.